Latest Health News

Smartgroup reports a solid start to 2025 with stable revenue and a surge in electric vehicle leasing orders, while cautiously navigating evolving government incentives and market conditions.

Super Retail Group has amended its FY25 sales growth figures while reporting improved like-for-like sales in the second half, alongside strategic investments in supply chain and store network expansion.

Super Retail Group updates key sales growth figures while outlining increased costs from system upgrades and distribution centre transitions, signaling a cautious outlook amid mixed retail conditions.

Super Retail Group reports steady sales growth driven by BCF and rebel brands, while facing increased costs from a new distribution centre and HR system upgrades.

Mayne Pharma has announced the expiration of the US antitrust waiting period, a critical step forward in Cosette Pharmaceuticals' proposed acquisition. The transaction now moves closer to completion, pending other regulatory and shareholder approvals.

Boss Energy reports a successful ramp-up to commercial production at its Honeymoon uranium mine, backed by a robust $229 million cash position and promising growth at its US Alta Mesa project.

JB Hi-Fi Limited reports robust sales growth across Australia and New Zealand in Q3 FY25, maintaining momentum in a competitive retail environment.

HyTerra Limited has confirmed hydrogen concentrations up to 96.1% in its Sue Duroche 3 well in Kansas, reinforcing the potential of its natural hydrogen exploration program. Elevated helium levels were also detected, with further testing planned to assess commercial viability.

Cardiex Limited has formally lodged its CONNEQT Pulse device with Australia's Therapeutics Goods Administration, marking a critical step toward regulatory approval and market expansion.

Global Uranium and Enrichment Limited has completed a scoping study for its Hansen Deposit in Colorado, revealing strong economic potential through innovative mining and beneficiation methods.

Southern Cross Media Group reports robust audio revenue growth exceeding expectations and signals a return to dividends for FY25, underpinned by disciplined cost management.

EZZ Life Science Holdings Limited has announced a fully franked ordinary dividend of AUD 0.02 per share for the six months ending December 2024, signaling steady returns for shareholders.